Literature DB >> 10675422

Subterminal viral DNA nucleotides as specific recognition signals for human immunodeficiency virus type 1 and visna virus integrases under magnesium-dependent conditions.

A L Morgan1, M Katzman.   

Abstract

Many reports describe the characteristics of susceptible viral DNA substrates to various retroviral integrases during in vitro reactions in which manganese serves as the divalent cation cofactor for site-specific nicking. However, manganese is known to alter the specificity of some endonucleases and magnesium may be the divalent cation used during retroviral integration in vivo. To address these concerns, we identified conditions under which the integrases of human immunodeficiency virus type 1 and visna virus were optimally active with magnesium (the first time such activity was shown for visna virus integrase) and used these conditions to test the susceptibility of a series of oligodeoxynucleotide substrates. The data show that two base pairs immediately internal to the conserved CA dinucleotide near the termini of retroviral DNA are selectively recognized by the two integrases and that the final six base pairs of viral DNA contain sufficient sequence information for specific recognition and cleavage by each enzyme. The results validate the importance of the subterminal viral DNA positions even in the presence of magnesium and identify viral DNA positions that functionally interact with integrase. The data obtained under magnesium-dependent conditions, which were obtained with substrates containing single and multiple base-pair substitutions and two different retroviral integrases, are consistent with those previously obtained with manganese. Thus, the large body of manganese-dependent data identifying terminal viral DNA positions that are important in substrate recognition by various integrases likely reflects interactions that are biologically relevant.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10675422     DOI: 10.1099/0022-1317-81-3-839

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  8 in total

1.  An amino acid in the central catalytic domain of three retroviral integrases that affects target site selection in nonviral DNA.

Authors:  Amy L Harper; Malgorzata Sudol; Michael Katzman
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

2.  A substitution in rous sarcoma virus integrase that separates its two biologically relevant enzymatic activities.

Authors:  Wesley M Konsavage; Stephen Burkholder; Malgorzata Sudol; Amy L Harper; Michael Katzman
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

3.  Use of patient-derived human immunodeficiency virus type 1 integrases to identify a protein residue that affects target site selection.

Authors:  A L Harper; L M Skinner; M Sudol; M Katzman
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

4.  HIV-1 integrase interaction with U3 and U5 terminal sequences in vitro defined using substrates with random sequences.

Authors:  Elena Brin; Jonathan Leis
Journal:  J Biol Chem       Date:  2002-03-15       Impact factor: 5.157

5.  Model of full-length HIV-1 integrase complexed with viral DNA as template for anti-HIV drug design.

Authors:  Rajeshri G Karki; Yun Tang; Terrence R Burke; Marc C Nicklaus
Journal:  J Comput Aided Mol Des       Date:  2005-06-27       Impact factor: 3.686

6.  A nonradioactive plate-based assay for stimulators of nonspecific DNA nicking by HIV-1 integrase and other nucleases.

Authors:  Malgorzata Sudol; Melissa Tran; Matthew G Nowak; John M Flanagan; Gavin P Robertson; Michael Katzman
Journal:  Anal Biochem       Date:  2009-09-11       Impact factor: 3.365

7.  LEDGF/p75 interacts with divergent lentiviral integrases and modulates their enzymatic activity in vitro.

Authors:  Peter Cherepanov
Journal:  Nucleic Acids Res       Date:  2006-12-07       Impact factor: 16.971

8.  Selection of functional mutations in the U5-IR stem and loop regions of the Rous sarcoma virus genome.

Authors:  Michael Johnson; Shannon Morris; Aiping Chen; Ed Stavnezer; Jonathan Leis
Journal:  BMC Biol       Date:  2004-05-20       Impact factor: 7.431

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.